<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39385221</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Predictors of seropositivity to SARS-CoV-2 among employees at a large urban medical center.</ArticleTitle><Pagination><StartPage>2754</StartPage><MedlinePgn>2754</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2754</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-20274-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Before SARS-CoV-2 vaccination availability, medical center employees were at high risk of COVID-19. However, risk factors for SARS-CoV-2 infection in medical center employees, both healthcare and non-healthcare workers, are poorly understood.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From September-December 2020, free IgG antibody testing was offered to all employees at a large urban medical center. Participants were asked to complete a questionnaire on work and non-work related risk factors for COVID-19 infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">SARS-CoV-2 seropositivity was found in 4.7%. Seropositivity was associated with close contact with COVID-19 cases with or without the use of adequate personal protective equipment (PPE), (OR 3.1 [95% CI 1.4-6.9] and OR 4.7 [95% CI 2.0-11.0] respectively), never wearing a mask outside of work (OR 10.1 [95% CI 1.9-57]), and Native Hawaiian/Pacific Islander race (OR 6.3 95% CI (1.6-25)].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among workers in a large urban medical center, SARS-CoV-2 seropositivity was associated with work-related COVID-19 close contacts and low mask use outside of work, suggesting that non-workplace close contacts are also relevant routes of COVID-19 spread among healthcare workers.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kupferwasser</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. dkupferwasser@lundquist.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lundquist Institute of Biomedical Innovation at Harbor-UCLA Medical Center, United States, 1124 W. Carson St, Torrance, CA, 90502, USA. dkupferwasser@lundquist.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores</LastName><ForeName>Evelyn A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merino</LastName><ForeName>Prudencio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Donna Phan</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Honghu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Section of Public and Population Health, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yilan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Section of Public and Population Health, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolaris</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Megan H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>School of Pharmacy &amp; Pharmaceutical Sciences, University of California, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales</LastName><ForeName>Mildred</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Los Angeles County College of Nursing and Allied Health, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Silva</LastName><ForeName>Wellington</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Los Angeles County + USC Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astorga-Cook</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Los Angeles County + USC Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abueg</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>Holli</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Loren G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>18CR-22614-01</GrantID><Agency>Merck</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067393" MajorTopicYN="N">Personal Protective Equipment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health system workforce</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Seropositivity</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39385221</ArticleId><ArticleId IdType="pmc">PMC11462861</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-20274-6</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-20274-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Organization WH, World Health Organization (WHO). (2021) Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update 2021 [ https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</Citation></Reference><Reference><Citation>Nguyen LH, Drew DA, Joshi AD, Guo CG, Ma W, Mehta RS et al. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. medRxiv. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491202</ArticleId><ArticleId IdType="pubmed">32745512</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagesh S, Chakraborty S. Saving the frontline health workforce amidst the COVID-19 crisis: challenges and recommendations. J Glob Health. 2020;10(1):010345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183244</ArticleId><ArticleId IdType="pubmed">32373323</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings KJ, Materna BL, Vergara X, Beckman J, Espineli C, Harrison R. COVID-19 in the Workplace: the View from California. Ann Am Thorac Soc. 2022;19(8):1260–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353959</ArticleId><ArticleId IdType="pubmed">35289735</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai DBG, Sia IG, Doubeni CA, Wieland ML. Disproportionate impact of COVID-19 on racial and ethnic minority groups in the United States: a 2021 Update. J Racial Ethn Health Disparities. 2022;9(6):2334–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8513546</ArticleId><ArticleId IdType="pubmed">34647273</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfaw A. Racial disparity in potential Occupational exposure to COVID-19. J Racial Ethn Health Disparities. 2022;9(5):1726–39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340801</ArticleId><ArticleId IdType="pubmed">34351611</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute CWC. 2023 [ https://www.cwci.org</Citation></Reference><Reference><Citation>Bobrovitz N, Arora RK, Cao C, Boucher E, Liu M, Donnici C, et al. Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis. PLoS ONE. 2021;16(6):e0252617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221784</ArticleId><ArticleId IdType="pubmed">34161316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayı İ, Madran B, Keske Ş, Karanfil Ö, Arribas JR, Psheniсhnaya N, et al. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27(9):1242–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186944</ArticleId><ArticleId IdType="pubmed">34116205</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto NM, Lee JE, Massai D, Zamarripa S, Sasaninia B, Khurana D et al. Correlates of COVID-19 Vaccine Acceptance, Hesitancy and Refusal among employees of a Safety Net California County Health System with an early and aggressive vaccination program: results from a cross-sectional survey. Vaccines (Basel). 2021;9(10).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8540702</ArticleId><ArticleId IdType="pubmed">34696260</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanis P, Vraka I, Fragkou D, Bilali A, Kaitelidou D. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. J Hosp Infect. 2021;108:120–34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668234</ArticleId><ArticleId IdType="pubmed">33212126</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan A, Pepper G, Wener MH, Fink SL, Morishima C, Chaudhary A et al. Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J Clin Microbiol. 2020;58(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383515</ArticleId><ArticleId IdType="pubmed">32381641</ArticleId></ArticleIdList></Reference><Reference><Citation>Laboratory A. SARS-CoV-2 IgG for use with ARCHITECT 2020 [updated 2022. https://www.fda.gov/media/137383/download</Citation></Reference><Reference><Citation>Champion VL. Use of the health belief model in determining frequency of breast self-examination. Res Nurs Health. 1985;8(4):373–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">3853250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupferwasser D, Flores EA, Merino P, Phan Tran D, Bolaris M, Gonzales M, et al. Characterization of COVID-19 vaccine hesitancy among essential workforce members of a large safety net Urban Medical Center. J Prim Care Community Health. 2023;14:21501319231159814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10028456</ArticleId><ArticleId IdType="pubmed">36941757</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon S, Joshi AD, Lo CH, Drew DA, Nguyen LH, Guo CG, et al. Association of social distancing and face mask use with risk of COVID-19. Nat Commun. 2021;12(1):3737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8213701</ArticleId><ArticleId IdType="pubmed">34145289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiggen TD, Bohn B, Ulrich AK, Stovitz SD, Strickland AJ, Naumchik BM, et al. SARS-CoV-2 seroprevalence among healthcare workers. PLoS ONE. 2022;17(4):e0266410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9037906</ArticleId><ArticleId IdType="pubmed">35468153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: a Survey of U.S. adults. Ann Intern Med. 2020;173(12):964–73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7505019</ArticleId><ArticleId IdType="pubmed">32886525</ArticleId></ArticleIdList></Reference><Reference><Citation>Fall E, Izaute M, Chakroun-Baggioni N. How can the health belief model and self-determination theory predict both influenza vaccination and vaccination intention ? A longitudinal study among university students. Psychol Health. 2018;33(6):746–64.</Citation><ArticleIdList><ArticleId IdType="pubmed">29132225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):2204–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553708</ArticleId><ArticleId IdType="pubmed">32730103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims MD, Maine GN, Childers KL, Podolsky RH, Voss DR, Berkiw-Scenna N, et al. Coronavirus Disease 2019 (COVID-19) seropositivity and asymptomatic rates in Healthcare Workers Are Associated with job function and masking. Clin Infect Dis. 2021;73(Suppl 2):S154–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665441</ArticleId><ArticleId IdType="pubmed">33150375</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal A, Trieu MC, Mohn KGI, Madsen A, Olofsson JS, Sandnes HH, et al. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. Front Public Health. 2023;11:1164326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10402899</ArticleId><ArticleId IdType="pubmed">37546332</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, et al. SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Sci Rep. 2021;11(1):8380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8052331</ArticleId><ArticleId IdType="pubmed">33863960</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt SB, Grüter L, Boltzmann M, Rollnik JD. Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff. PLoS ONE. 2020;15(6):e0235417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316280</ArticleId><ArticleId IdType="pubmed">32584894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr NM, Krishnadasan A, Harland KK, Ten Eyck P, Mower WR, Schrading WA, et al. Emergency department personnel patient care-related COVID-19 risk. PLoS ONE. 2022;17(7):e0271597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307202</ArticleId><ArticleId IdType="pubmed">35867681</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, van der Westhuizen H-M, et al. An evidence review of face masks against COVID-19. Proc Natl Acad Sci. 2021;118(4):e2014564118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848583</ArticleId><ArticleId IdType="pubmed">33431650</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiner RC, Barber RM, Collins JK, Zheng P, Adolph C, Albright J, et al. Modeling COVID-19 scenarios for the United States. Nat Med. 2021;27(1):94–105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7806509</ArticleId><ArticleId IdType="pubmed">33097835</ArticleId></ArticleIdList></Reference><Reference><Citation>Penaia CS, Morey BN, Thomas KB, Chang RC, Tran VD, Pierson N, et al. Disparities in native hawaiian and Pacific Islander COVID-19 Mortality: A Community-Driven Data Response. Am J Public Health. 2021;111(S2):S49–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8495640</ArticleId><ArticleId IdType="pubmed">34314211</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and Racial/Ethnic disparities. JAMA. 2020;323(24):2466–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9310097</ArticleId><ArticleId IdType="pubmed">32391864</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder JM. The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clin Infect Dis. 2021;72(4):707–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454466</ArticleId><ArticleId IdType="pubmed">32648581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaholokula JK, Samoa RA, Miyamoto RES, Palafox N, Daniels SA. COVID-19 special column: COVID-19 hits native hawaiian and Pacific Islander communities the hardest. Hawaii J Health Soc Welf. 2020;79(5):144–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7226312</ArticleId><ArticleId IdType="pubmed">32432218</ArticleId></ArticleIdList></Reference><Reference><Citation>Block P, Hoffman M, Raabe IJ, Dowd JB, Rahal C, Kashyap R, et al. Social network-based distancing strategies to flatten the COVID-19 curve in a post-lockdown world. Nat Hum Behav. 2020;4(6):588–96.</Citation><ArticleIdList><ArticleId IdType="pubmed">32499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Education LACOo. Los Angeles County District school closure list 2023 [ https://www.lacoe.edu/Home/News-Announcements/Coronavirus-School-Closures</Citation></Reference><Reference><Citation>Ahmad K, Erqou S, Shah N, Nazir U, Morrison AR, Choudhary G, et al. Association of poor housing conditions with COVID-19 incidence and mortality across US counties. PLoS ONE. 2020;15(11):e0241327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605696</ArticleId><ArticleId IdType="pubmed">33137155</ArticleId></ArticleIdList></Reference><Reference><Citation>Champion VL. Instrument development for health belief model constructs. ANS Adv Nurs Sci. 1984;6(3):73–85.</Citation><ArticleIdList><ArticleId IdType="pubmed">6426380</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercadante AR, Law AV. Will they, or won’t they? Examining patients’ vaccine intention for flu and COVID-19 using the Health Belief Model. Res Social Adm Pharm. 2021;17(9):1596–605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833824</ArticleId><ArticleId IdType="pubmed">33431259</ArticleId></ArticleIdList></Reference><Reference><Citation>Noah BA. The participation of underrepresented minorities in clinical research. Am J Law Med. 2003;29(2–3):221–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">12961806</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>